Comparative Efficacy of Zonisamide and Pregabalin as an Adjunctive
Therapy in Children with Refractory Epilepsy
Introduction
Every year about 40 out of 100,000 children under 16 years of age are affected by epilepsy as one of the most widespread neurologic disorders worldwide (1) . Approximately one third of epileptic children do not achieve complete seizure improvement in spite of equal or more two antiepileptic therapies, i.e. refractory epilepsy (2) (3) . Election of the most suitable anticonvulsant for an epileptic patient regarding new AEDs utility in treatment of children with refractory epilepsy, the current assay was carried out to evaluate the effectiveness, safety, and tolerability of pregabalin as an adjunctive therapy relative to that of Zonisamide.
Materials & Methods
From April 2012 to November 2012,121 children were referred to Mofid Children's Hospital with intractable epilepsy (failure of seizure recovery in spite of two or more antiepileptic drugs) and were enrolled in the study. Exclusion criterion was hypersensitivity to anticonvulsants and having a neurodegenerative disease. All parents endorsed a written informed consent. The initial assessment included history taking (seizure type, onset, etiology and frequency, period of the treatment, type of antiepileptic drug usage), general and neurologic physical examination, electroencephalography (EEG), and magnetic resonance imaging (MRI) performance. Then, the patients were divided into two groups randomly (A and B 
Results
In this study, 137 patients were enrolled and121 patients reached the final stage. (6) (7) (8) (9) (10) (11) . Pregabalin (PGB) has the structural equivalent of GABA but has no effects associated with GABA or GABA receptors (12) .PGB is a selective high-propensity ligand for the α2-δ subunit of presynaptic voltage gated calcium channels. Intense binding to this channel diminishes calcium entrance at hyper excitable nerve terminations to lower the distribution of several neurotransmitters consisting of glutamate, norepinephrine, and substance P.A reduction of these neurotransmitters and neuronal excitability that this drug acts on leads to it as an anticonvulsant, analgesic, and anxiolytic efficacy (13) (14) (15) (16) .It has a linear dose-concentration curve that is among the most effectual dose span (150-600 mg/day) and extensively absorbed after oral dosing with 90% bio availability that after1 h reaches peak plasma concentrations. PGB is much more vigorous (2 to 18 fold) than gabapentin between all seizure types tested (17) .Efficacy of PGB as an add-on therapy for patients with refractory partial epilepsies was evaluated through several controlled trials (18) (19) 
Discussion
This study showed that ZNS and PGB reduced greater than 50% of the seizure intensity in 40.2% and 45.8% of patients also had seizure frequency declinesof35.8% and 44.4%, respectively in which there was no significant superiority between these two novel anticonvulsants. Brodie et al, Sackellares et al, Faught et al, and Schmidt et al reported a response rate (greater than 50% seizure reduction) of 28-47% with ZNS as an add-on therapy for intractable epilepsy through four clinical studies (20) . ZNS effectiveness in the current assay is in agreement with Coppola et al and Stephen who declared a frequency decline of greater than 50% between 48.7-39% of patients, respectively (21) (22) .No preference between these two drugs that we found is different from Claudia B et al and Yuen et al who estimated that with a ZNS retention rate of 31% compared to 24% for PGB after six months period (23) (24) .In our review, the efficacy of both drugs has been diminished after six months of ( In conclusion, in this survey both pregabalin and Zonisamide were impressive for seizure control in children with intractable epilepsy and well sustained with mild complications that were completely reversible. Acknowledgments We are grateful to the Pediatric Neurology Research Center of Shahid Beheshti University of Medical Science for supporting this study.
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treatment towards one month of consumption. Loscher et al has observed that the efficacy of antiepileptic drugs decreased over time due to drug receptor sensitivity decreases that led to pharmaco dynamic tolerance that can further lead to loss of drug function completely or could interfere with other anticonvulsant activity via cross tolerance (25) .Similar to our results, Arroyo et al stated that 43.5% of patients with refractory epilepsy responded to PGB therapy. Furthermore, this study found a dose-dependent response to this drug at the higher dose equal to 600 mg per day was quite effective (15) .Terence et al examined the effects of lamotrigine compared with pregabalin on refractory partial seizures in a 17-week treatment period and concluded that PGB reduced greater than 50% of seizure intensity in 35.5% of cases toward the lamotrigine efficacy in 21.4% of patients (26) .Lee et al observed seizure declines in 46.2% of patients after 13 weeks of PGB treatment, which confirmed our result (27) . Elger et al detected PGB antiepileptic efficacy more than our results who treated patients with a constant dose of PGB (600mg/day) and later 12 weeks found 49.3% seizure improvement (19) .This discrepancy may be due to a wide spectrum of PGB dosage (5-15mg/kg/day), which takes a few weeks to achieve a fixed amount of the drug's availability in patients. Pradeep found a significant PGB induced reduction in the frequency and severity of seizures of up to 56% among patients with various seizure types and those who had previously not responded to gabapentin had no response to PGB (28) . Our study showed that three patients who had used gabapentin previously did not respond to PGB against Pradeep's results. The highest response to ZNS in our case was obtained in seizure types of infantile spasms (66.4%), myoclonic (54.5%), and generalized tonic clonic (50.9%) with no effect on mixed type seizures. Partial seizures (61.7%), tonic (55%), and generalized tonic clonic (40.9%) were the seizure kinds with the highest response to PGB in our patients with no effect on myoclonic seizure. PGB and ZNS had complication rate of 18.33-16.4%, respectively. Decreased appetite, impaired speech, ataxia, sigh, visual disturbances, hallucinations, and dizziness versus increased appetite, increased urination, hallucinations, and headache have been the most prevalent side effects of ZNS and PGB, respectively. All of our patients' complications 
